DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Dr. Reddy’s Laboratories

Strategy & Management

Experts Statements: Ravi Venkataramanan, Dr. Reddy’s Laboratories

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...

News

Lilly Wins Alimta Appeal

23.08.2019 - US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories. The US...

News

Pfizer Loses Patent Appeal Against Allergan

17.10.2016 - Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...

News

Teva Wins US Nod for Allergan’s Generics

29.07.2016 - Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!